Compare Danaher Corporation (DHR) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Nvidia Corp — how do they compare? Danaher Corporation trades at $201.13 (market cap $140.88B), while Nvidia Corp trades at $210.13 (market cap $5.13T). The key difference: Nvidia Corp is far larger — about 36.4× Danaher Corporation's market cap, and Danaher Corporation pays the higher dividend (0.8%). Which is the better fit depends on your goals.
| DHR | NVDA | |
|---|---|---|
Market Cap | $140.88B | $5.13T |
Sector | Health | Technology |
52-Week High | $242.05 | $235.75 |
52-Week Low | $161.91 | $165.17 |
Enterprise Value | $153.66B | $5.06T |
Dividend Yield | 0.8% | 0.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
NVIDIA (NVDA) trades at $212.79, up 4.55% today, with a bullish technical signal and strong fundamentals. The stock shows robust revenue growth, with Q1 2026 EPS beating expectations at $1.87 versus $1.76. Key support is at $201, with resistance at $212. Analysts maintain a 75% buy rating, citing AI leadership and expanding margins.
Outlook remains positive due to AI demand and earnings momentum, but risks include competition and market volatility. The consensus price target is $325.86, offering significant upside. Investors should weigh high valuation multiples against sustained profitability and growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
